Cancer Family

Melanocytic Neoplasm

Non-malignant609 active trials13 approved drugs233 evidence items

NCIt: C7058

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (185)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 26–50 of 185 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Microwave therapy for the treatment of cutaneous melanoma metastases - A pilot study.
Daniel O'Driscoll, Purevsuren Losol, Andres Vallejo Pulido et al. · J Eur Acad Dermatol Venereol · Sep 1, 2026 · PMID 41910004 · candidate dictionary pubmed
Correction: Genomics of Primary and Metastatic Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
Manh Duc Hoang, Thi Oanh Bui, Van Tu Dao et al. · Am J Clin Dermatol · Sep 1, 2026 · PMID 42658469 · candidate dictionary pubmed
Genomics of Primary and Metastatic Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
Manh Duc Hoang, Thi Oanh Bui, Van Tu Dao et al. · Am J Clin Dermatol · Sep 1, 2026 · PMID 42133201 · candidate dictionary pubmed
Polygenic Risk Scores and Its Association With Cutaneous Melanoma Risk in the Swedish Population.
Hildur Helgadottir, Muyi Yang, Ivette Raices Cruz et al. · Pigment Cell Melanoma Res · Sep 1, 2026 · PMID 42754918 · candidate dictionary pubmed
A machine learning-derived intratumoral heterogeneity-related signature predicts the prognosis for and therapeutic response in patients with skin cutaneous melanoma.
Feng Ding, Wei Tian, Sarina Bai et al. · Transl Cancer Res · Aug 31, 2026 · PMID 42724746 · candidate dictionary pubmed
Natural Product Toosendanin Suppresses the Malignant Development of Skin Melanoma by Targeting BNC2 for Degradation.
Hui Dai, Xin Mei Zhang, Jing Cheng Zhang et al. · Adv Sci (Weinh) · Aug 30, 2026 · PMID 42669594 · candidate dictionary pubmed

Occupational solar UV-exposure and risk of cutaneous melanoma among Danish workers: A nationwide cohort study.

Ida Kristensen, Sigrun Alba Johannesdottir Schmidt, Alexander Wilhelm Gorny et al. · Eur J Cancer · Aug 26, 2026 · PMID 42308861 · candidate dictionary pubmed

Trends in Cutaneous Melanoma in the United States Using SEER.

Saad Badat, Mustafa M Houmsse, Nathan J Fakult et al. · J Am Acad Dermatol · Aug 24, 2026 · PMID 42637051 · candidate dictionary pubmed

Association of Neighborhood Deprivation With Breslow Thickness in Head and Neck Cutaneous Melanoma.

Evan A Thomas, Michael J Davis, Chaz L Stucken et al. · Laryngoscope · Aug 22, 2026 · PMID 42631534 · candidate dictionary pubmed

IL1RAP Is Associated With an Inflammation-Immunity-Related State in Skin Cutaneous Melanoma: Integrative Evidence From Pan-Cancer Data and Melanoma Immunotherapy Cohorts.

Chenxi Jiang, Hairui Li, Jianqiong Huang et al. · Int J Genomics · Jan 1, 2026 · PMID 42683052 · candidate dictionary pubmed

RAB37 Exerts a Context-Dependent Role in Cutaneous Melanoma Progression by Promoting Tumor Cell Proliferation and Being Associated with Favorable Immune Characteristics.

Meng Zhu, Yanna Wang, Yanting Zhang et al. · Cancer Manag Res · Jan 1, 2026 · PMID 42644154 · candidate dictionary pubmed

Molecular reprogramming in cutaneous melanoma: the central role of G9a and EZH2 methyltransferase inhibitors in tumor plasticity, immune evasion, and therapeutic resistance.

Melissa Yoshimi Sakamoto Maeda Nisimoto, Daniel Arcuschin de Oliveira, Heitor Raia Bottura et al. · Front Pharmacol · Jan 1, 2026 · PMID 42756612 · candidate dictionary pubmed

Ultrasound radiomics integrated with an immune-related gene signature for predicting response and resistance to immune checkpoint inhibitors in cutaneous melanoma: a retrospective radiogenomic study with biological validation.

Jinyu Peng, Bowen Dai, Kan Ze et al. · Front Genet · Jan 1, 2026 · PMID 42765081 · candidate dictionary pubmed

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

· N Engl J Med · 2011 · PMID 21639808 · validated civic_curation pubmed

Improved overall survival in melanoma with combined dabrafenib and trametinib.

· N Engl J Med · 2015 · PMID 25399551 · validated civic_curation pubmed

Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial.

· Lancet Oncol · 2016 · PMID 27480103 · validated civic_curation pubmed

Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial.

· Lancet Oncol · 2018 · PMID 29573941 · validated civic_curation pubmed

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.

· Lancet · 2020 · PMID 32534646 · validated civic_curation pubmed